Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders

Neuroendocrinology Letters

Volumn 30, Issue 5, 2009, Pages 604-609

  Paclt, Ivo ^a   Koudelova, Jitka ^a   Pacltova, Dagmar ^b   Kopeckova, Marta ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Department of General Practitioner for Children and Adolescent ^*  (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

ADHD; Child depression; Child schizophrenia; Dopamine beta hydroxylase; Noradrenergic system

Indexed keywords

CLOMIPRAMINE; DOPAMINE BETA MONOOXYGENASE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; SCHOOL CHILD;

EID: 77649249868     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Barkley RA, Smith KM, Fischer M, Navia B (2006). An Examination of the Behavioral and Neuropsychological Correlates of Three ADHD Candidate Gene Polymorphisms (DRD4-7, DBH Taql A2, and DAT1 40 bp VNTR) in Hyperactive and Normal Children Followed to Adulthood. Am. J. Med. Gen. Part B. 141B: 487-498.
2. Baron M, Levitt M, Perlman R (1980). Plasma DBH activity: Relation to genetic factors in schizophrenia. Commun. Psychopharmacol. 4: 197-202.
3. Belmarker RH, Hattab J, Ebstein RP (1978). Plasma dopamine-beta- hydroxylase in childhood psychosis. J. Aut. Child. Schizo. 8: 293-298.
4. Bowden CL, Deutsch CK, Swanson JM (1988). Plasma dopamine-beta- hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J.Am.Acad.Child and Adolescent.Psychiatry. 27(2): 171-4.
5. Carrasco X., Rothhammer P, Moraga M, Henriq H, Chakraborty R,. Aboitiz F, et al (2006). Genotypic Interaction Between DRD4 and DAT1 Loci Is a High Risk Factor for Attention-Deficit/Hyperactivity Disorder in Chilean Families. Am. J. Med. Genet. Part B. 141B: 51-54.
6. Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, et al (1998). Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet. 102(5): 533-40.
7. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, et al (2000). A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry. 5(1): 56-63.
8. Dunner DL, Cohn CK, Weinshilboum RM (1973). The activity of dopamine-beta-hydroxylase and methionine-activating enzyme in blood of schizophrenic patients. Biol. Psychiatry. 6: 215-220.
9. Eberhard G, Ross S, Saaf J, Wahlund B, Wetterberg L. Psychoses in twins. A 10 year clinical and biochemical follow-up study. Schizophr. 1989; 2:367-374.
10. Fujita K, lto T, Maruta K (1978). Serum dopamine-beta-hydroxy-lase in schizophrenic patients. J. Neurochem. 30: 1569-1572.
11. Gabel S, Stadler J, Bjorn J, Shindledecker R, Bowden CL (1993). Biodevelopmental aspects of conduct disorder in boys. Child Psych. Hum. Dev. 24(2): 125-141.
12. Galvin M, TenEyck R, Shekhar A, Stilwell B, Fineberg N, Laite G, et al (1995). Serum dopamine-beta-hydroxylase and maltreatment in psychiatrically hospitalized boys. Child Abuse and Neglected. 19(7): 821-832.
13. Galvin M, Stilwell BM, Shekhar R, Kopta SM, Goldfarb SM (1997). Maltreatment, conscience fuctioning and dopamine-beta-hydroxylase in emotionally disturbed boys. Child Abuse and Neglected. 21(1): 83-92.
14. Gerring IP, Grady RD, Chen A, Vasa R, Grados M, Bandeen-Roche KJ, et al (1998). Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Child Adolesc Psychiatry. 17: 647-654.
15. Goldstein M, Freedman LS, Ebstein RD (1974). Studies of dopamine-beta-hydroxylase in mental disorders. J. Psychiatr. Res. 11: 205-210.
16. Honecker H, Fahrdrich E, Coper H, Helmchen H (1981). DBH and MAO in patients with depressive disorders. Pharmacopsychiatry. 14: 10-14.
17. Ishii A, Kobayashi K, Kiuchi K, Nagatsu T (1991). Expression of two forms of human dopamine-beta-hydroxylase in COS cells. Neurosci Lett. 125(1): 25-8.
18. Kammen DP, Mann LS, Sternberg DE, Ninan PT, Marder S, Kammen WB, et al (1983). Dopamine-beta-hydroxylase and homovanillic acid in spinal fluid of schizophrenics with brain atrophy. Science. 220: 974-977.
19. Kim SJ, Badner J, Cheon KA, Kim BN, Yoo HJ, Kim SJ, et al (2006). Family-Based Association Study of the Serotonin Transporters Gene Polymorphisms in Korean ADHD Trios. Am. J. Med. Genet. Part B. 139B: 14-18.
20. Kopecková M, Paclt I, Petrásek J, Pacltová D, Malíková M, Zagatová V (2008). Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol Lett. 29(2): 246-51.
21. Koudelová J, Paclt I, Mourek J, Trojan S (1989). Variability in dopamin-betahydroxylase activity in plasma of rats (the effect of age and of hypoxia in plasma of children with mental disorders). In: Van Loun CR, Kvetňanský K, McCarthy R and Axelrod J, editors. Stress: Neurochemical and Humoral Mechanismus. New York: Gordon and Break Science Publishers, S. A. 967-974.
22. Lake CR, Sternberg DE, Van Kammen DP (1980). Schizopfrenia: Elevated cerebrospinal fluid norepinephrine. Science. 207: 331-333.
23. Lamprecht F, Ebert MH, Turek I, Kopin KJ (1974). Serum dopamine-beta-hydroxylase in depressed patients and the effect of electro convulsive shock treatment. Psychopharmacology. 40: 241-248.
24. Lerner P, Gooewin K, Van Kammen DP (1978). Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. Biol. Psychiatry. 13: 685-694.
25. Levitt M, Cho HW, Carrol BJ, Russo P (1976). Serum dopamine-beta- hydroxylase activity in affective psychoses and schizophrenia. Arch. Gen. Psychiatry. 33: 585-591.
26. Lewis DA, Hayes TL, Lund JS, Oeth KM (1992). Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research. Neuropsychopharmacology. 6(2): 127-34.
27. Markianos ES, Nystrom I, Reichel H, Matussek N (1976). Serum Dopamine-beta-Hydroxylase in Psychiatric Patients and Normals. Effect of d-Amphetamine and Haloperidol. Psychopharmacology. 50: 259-267.
28. Markianos M, Rinieris P, Hatzimanolis J, Stefanis C 1990). Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia. Biol. Psychiatry. 1176-1178.
29. Meyer BS, Alexopoulos GS, Kakuma T, Tirumalasetti F, Gabriele M, Alpert S, et al (1999). Decreased dopamine beta-hydroxylase Activity in unipolar geriatric delusional depression. Biol. Psychiatry. 45: 448-552.
30. Meltzer HY, Tong CH, Luchins DJ (1984). Serum dopamine-beta-hydroxylase and lateral ventricular size in affective disorders and schizophrenia. Biol. Psychiatry. 19:1395-1402.
31. Melzer HY, Cho HW, Carroll BJ, Russo P (1974). Serum dopamine-beta- hydroxylase activity in the affective psychoses and schizophrenia. Arch. Gen. Psychiatry. 33: 585-591.
32. Nagatsu T, Kato T, Numata Y (Sudo), Ikuta K, Umezawa H, Matzuzaki M, et al (1974). Serum dopamine-beta-hydroxylase activity in developing hypertensive rats. Nature Lond. 251: 630-631.
33. Paclt I (1993). Antipsychotic drugs in therapy of child psychoses, (in Czech) Čes. slov. Psychiatr. 1: 20-23.
34. Paclt I, Florian J (1998). Psychofarmakoterapie dětského a dorostového věku. Grada. 405.
35. Paclt I, Koudelová J (1990). Dopamin-beta-hydroxylase in plasma of psychiatric patients. Activ. nerv. super. 32(1 ): 67.
36. Puzynski S, Rode A, Zaluska M (1983a). Studies on biogenetic amines metabolising enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression. Acta Psychiatr. Scand. 67: 89-95.
37. Puzynski S, Rode A, Zaluska M (1983b). Studies on biogenetic amines metabolising enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression. Acta Psychiatr. Scand. 67: 101-108.
38. Queiroz EA, Lombardi AB, Furtado CR, Peixoto CC, Soares TA, Fabre ZL, et al (1993). Biochemical correlate of depression in children. Arq. Neuropsiquiatr. (Brazil). 49: 418-425.
39. Rihmer Z, Bagdy G, Arató M (1984). Serum Dopamine-beta-Hydroxylase Activity in Female Manic-Depressive Patients. Biol. Psychiatry. 19: 423-427.
40. Rogeness GA, Crawford L, McNamara A (1989a). Plasma dopamine-beta- hydroxylase and preschool behaviour in children with conduct disorder. Child Psychiatry Hum. De. 20(2):149-156.
41. Rogeness GA, Maas JW, Javors MA, Macedo CA, Fischer C, Harris WR (1989b). Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res. 27(3):241-251.
42. Sapru MK, Rao BSSR, Channabasavanna SM (1989). Serum dopamine beta-hydroxylase activity in clinical subtypes of depression. Acta Psychiatr Scand. 80: 474-478.
43. Schatzberg AF, Rothschield AJ (1992). Psychotic (delusional) major depression: Should it be included as a distinct syndrome in DSM-IV? Am. J. Psychiatry. 149: 733-745.
44. Shopsin B, Freedman LS, Goldstein M, Gershon S (1972). Serum dopamine-beta-hydroxylase activity and affective states. Psychopharmacology. 27: 11-16.
45. Sofuoglu S, Dogan P, Koesek K, Esel E, Bastuck M, Oguz H, et al (1995). Changes in platelet monoamine oxidase and plasma dopamine-beta- hydroxylase activities in lithium-treated bipolar patients. Psychiatry Res. 59: 165-170.
46. Standman E, Wetterberg L, Perris C, Ross SB (1978). Serum dopamine-beta-hydroxylase in affective disorders. Neuropsychobiology. 4: 248-255.
47. Tang Y, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2005). Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C > T) with plasma dopamine beta-hydroxylase activity. Am. J. Med. Genet. Part B. 139(1): 88-90.
48. Wei J, Ramchand CN Hemmings GP (1997). Possible control of dopamine beta-hydroxylase via a co dominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet. 99(1): 52-5.
49. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1973). Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. Science. 181(103): 943-5.
50. Wetterberg L, Aberg H, Ross SB (1972). Plasma dopamine-beta-hydroxylase activity in hypertension and various neuropsychiatry disorders. Scand. J. Clin. Lab. Invest. 30: 283-289.
51. Wigg K, Zai G, Schachar R, Tannock R, Roberts W, Malone M, et al (2002). Attention deficit hyperactivity disorder and the gene for dopamine Beta-hydroxylase. Am J Psychiatry. 159(6): 1046-8.
52. Young JG, Kyprie RM, Ross NT, Cohen DJ (1980). Serum Dopamine-Beta- Hydroxylase Activity: Clinical Applications in Child Psychiatry. J Autism Dev Disord. 10: 1.
53. Yu PH, O'Sullivan KS, Keegan D, Boulton AA (1980). Dopamine-beta- hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients. Psychiatry Res. 3: 205-210.
54. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, et al (2001). A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet. 68(2): 515-22.